Redmond Cavan M. 4
4 · BIOTIME INC · Filed Jul 3, 2018
Insider Transaction Report
Form 4
BIOTIME INCBTX
Redmond Cavan M.
Director
Transactions
- Award
Option to Purchase Common Shares
2018-07-01+40,000→ 40,000 totalExercise: $2.06Exp: 2023-06-30→ Common Shares (40,000 underlying)
Holdings
- 60,000
Option to Purchase Common Shares
Exercise: $2.64Exp: 2023-02-20→ Common Shares (60,000 underlying)
Footnotes (2)
- [F1]Will become exercisable on June 30, 2019, based upon continued service on the board of directors.
- [F2]Will become exercisable on February 21, 2019, based upon continued service on the board of directors.